Welcome to our dedicated page for Meta Platforms SEC filings (Ticker: META), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Meta Platforms, Inc. filings document the regulatory record of a Nasdaq-listed operating company with Class A common stock registered under the Exchange Act. Form 8-K reports cover operating and financial results, GAAP and non-GAAP reconciliations, Regulation FD disclosure practices, material events, and changes involving directors or other governance matters.
Meta’s filing record also includes shelf registration and prospectus-supplement disclosures for underwritten senior note offerings, along with underwriting agreements and debt-security terms. Definitive proxy materials document annual-meeting matters such as director elections, executive compensation, security ownership, related-party transactions, responsible business practices, Audit & Privacy Committee reporting, auditor ratification, and shareholder proposals.
Meta Platforms, Inc. (META) received a notice from company officer Andrew Bosworth of a proposed sale of Class A common stock under SEC Rule 144. The filing covers up to 7,848 shares, to be sold through Charles Schwab & Co., Inc. on NASDAQ, with an aggregate market value of $4,379,184.00 at the time of the notice. The shares relate to a Restricted Stock Unit lapse scheduled for 08/15/2026 and are characterized as equity compensation. The notice states that the shares will be sold pursuant to a Rule 10b5-1 trading plan.
In the prior three months, Bosworth reported sales of 7,847 shares of Meta Class A common stock, with an aggregate market value of $4,769,642.00.
Meta Platforms, Inc. (META) received a notice that officer Susan J. Li, as trustee of The Li-Hegeman Living Trust, intends to sell 9,196 Class A common shares under Rule 144. These shares relate to a restricted stock unit lapse and are covered by a Rule 10b5-1 trading plan. A prior sale of 9,195 shares of Meta Class A common stock occurred on 05/18/2026 from the same trust.
Meta Platforms, Inc. (META) received a notice that officer Curtis J. Mahoney plans to sell 1,559 Class A common shares under Rule 144. The shares arise from a Restricted Stock Unit lapse and will be sold pursuant to a Rule 10b5-1 trading plan. In the prior three months, Mahoney sold 2,079 Meta shares under Rule 144.
Meta Platforms, Inc. Chief Operating Officer Javier Olivan reported multiple sales of an aggregate 1,692 shares of Class A Common Stock on August 10, 2026, at prices between $600.00 and $607.14 per share. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on November 17, 2025. Following these transactions, entities associated with Olivan held 6,490 shares through Olivan D LLC, 1,517 shares through Olivan Reinhold D LLC, 6,490 shares through Reinhold D LLC, and 79,885 shares through the Olivan Reinhold Family Revocable Trust.
Meta Platforms insider Javier Olivan filed a notice of proposed sale of 1,692 Class A Common Shares, to be handled through Charles Schwab & Co. The shares relate to multiple restricted stock unit lapses between 2018 and 2026 granted as equity compensation.
The filing also lists recent sales of Meta Class A Common Stock over the prior three months, with individual transactions ranging from 1,398 to 5,235 shares and aggregate proceeds per transaction between $838,800.00 and $3,145,422.00.
An entity associated with Meta Platforms director Marc Andreessen reported open-market sales of 426 shares of Meta Class A Common Stock on August 4, 2026, through a16z Capital Management, L.L.C., in four tranches at weighted average prices between approximately $587.68 and $592.27 per share.
The 426 shares sold had previously been received by a16z Capital via pro rata distributions in kind from Andreessen Horowitz funds, which the footnotes describe as a change in form of beneficial ownership under Rule 16a-13. After these distributions, affiliated vehicles reported indirect holdings of 20,951 shares by Andreessen Horowitz Fund VIII, L.P. and 49,448 shares by the LAMA Community Trust, with Andreessen disclaiming beneficial ownership except to the extent of any pecuniary interest.
FMR LLC and Abigail P. Johnson report passive ownership of Meta Platforms Inc. Class A common stock in an amended Schedule 13G filing. As of June 30, 2026, they beneficially own 96,176,347.85 shares, representing 4.4% of the class. FMR LLC has sole voting power over 88,062,892.59 shares and sole dispositive power over the full 96,176,347.85 shares, with no shared voting or dispositive power reported. The filing notes that one or more other persons may receive dividends or sale proceeds from these shares, but no single such person holds more than five percent of the outstanding Class A common stock.
Meta Platforms, Inc. director Robert M. Kimmitt sold 500 shares of Class A Common Stock on August 3, 2026 at an average price of $561.56 per share. Following this sale, he holds 2,943 shares directly. The transaction was executed under a Rule 10b5-1 trading plan adopted on February 25, 2026.
Meta Platforms director Peggy Alford reported selling 464 shares of Class A Common Stock on July 31, 2026 at $543.56 per share. The trade was effected under a Rule 10b5-1 trading plan adopted on November 25, 2025. After this transaction, 2,840 shares are held indirectly through the Alford Family Revocable Trust, jointly by Alford and spouse as trustees.
Meta Platforms insider Mark Zuckerberg, through entities he controls, completed a conversion and charitable transfer on July 31, 2026. CZI Holdings, LLC converted 591,690 shares of Class B Common Stock into the same number of Class A shares, then transferred those Class A shares as a bona fide gift to Chan Zuckerberg Biohub, Inc. CZI Holdings, LLC reported 100,119,267 Class B shares outstanding after the conversion, while Chan Zuckerberg Biohub held 1,231,037 Class A shares. Zuckerberg is deemed to have sole voting and investment power over both entities’ holdings, but has no pecuniary interest in the shares held by Chan Zuckerberg Biohub.